Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Flu news: Study in 8,475 young children points to a more effective influenza vaccine

02.05.2006


Intranasal influenza vaccine compared to shots in a phase 3 study; Data announced today at Pediatric Academic Societies Annual Meeting



An intranasal influenza vaccine proved to be more effective than the injectable influenza vaccine in children older than 6 months and younger than 5 years of age, according to study data presented today at the annual meeting of the Pediatric Academic Societies in San Francisco.

The results point to a new way of looking at how to best protect very young children from various influenza strains, said Robert Belshe, M.D., a Saint Louis University researcher who is presenting the results today.


"We tested this needle-free vaccine in more than 8,000 children at 249 sites in 16 countries," said Dr. Belshe, director of the Center for Vaccine Development at Saint Louis University School of Medicine. "We discovered that the intranasal vaccine was significantly more effective in protecting these children against influenza infection than the injectable flu shot. This is especially significant because this age group is among the most vulnerable to flu infection, and they tend to spread influenza around to other family members."

The data indicate that the intranasal vaccine candidate, known as CAIV-T (Cold Adapted Influenza Vaccine Trivalent), was 55 percent more effective than the injectable vaccine in reducing influenza-like illness in children.

This is the largest head-to-head influenza vaccine study ever conducted. The trial included nearly 8,500 children, with about half receiving the U.S. Food and Drug Administration (FDA)-approved injectable and the other half receiving the nasal spray influenza vaccine.

Belshe said influenza vaccine must be manufactured several months before the influenza season, so in some years there’s a vaccine "mismatch" with the strain of flu that is circulating. This has happened four out of the last eight years. The study results also indicated that this nasal spray vaccine is more effective than shots against influenza A strains and also more effective in years in which the circulating strain of influenza is "mismatched" with that contained in the seasonal vaccine.

"The nasal spray vaccine showed high efficacy in years when epidemic flu viruses were not well matched to the recommended vaccine antigen," Belshe said. "This sort of broad protection from a live, attenuated intranasal vaccine suggests that this vaccine has properties that make it superior to the traditional flu shot."

FluMist® (Influenza Vaccine Live, Intranasal) is the only currently marketed live, attenuated, intranasal vaccination option for healthy children and adults between the ages of 5 and 49 years. CAIV-T is the investigational, next-generation, refrigerator-stable formulation of FluMist.

Study participants were randomized to receive either FluMist or the injectable influenza vaccine during the 2004-2005 influenza season. Each participant received a placebo nasal spray or placebo injection to preserve the double-blind design of the study. Participants also were followed through the influenza season and evaluated to identify illnesses caused by influenza virus. The trial included a record 6,384 previously unvaccinated children, with nearly 50 percent of those children less than 2 years of age.

Joe Muehlenkamp | EurekAlert!
Further information:
http://www.slu.edu

More articles from Studies and Analyses:

nachricht Europe’s Demographic Future. Where the Regions Are Heading after a Decade of Crises
10.08.2017 | Berlin-Institut für Bevölkerung und Entwicklung

nachricht Scientists reveal source of human heartbeat in 3-D
07.08.2017 | University of Manchester

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

A Map of the Cell’s Power Station

18.08.2017 | Life Sciences

Engineering team images tiny quasicrystals as they form

18.08.2017 | Physics and Astronomy

Researchers printed graphene-like materials with inkjet

18.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>